Genicular Nerve Block with bupivacaine and preservative free dexamethasone for anterior cruciate ligament injuries

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jan 2023: Trial started, NCT05720949
  2. 9 Feb 2023: Trial registered, NCT05720949

The trials

NCT05720949: Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery

State
Completed
Phase
Phase 4
People
192 taking part
Started
12 Jan 2023
Primary completion
26 Nov 2024
Arms
Group 2 - Intervention
Results
Posted on the registry
  1. 12 Jan 2023: Trial started
  2. 9 Feb 2023: Trial registered
  3. 2 Dec 2024: Trial completed
  4. 26 Jan 2026: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.